1-9 of 9
A. Robert Turner, MD FRCPC
Close
Sort by
Journal Articles

Novel Evidence That Pituitary Gonadotropins Directly Stimulate Human Leukemic cells—studies on Myeloid Cell Lines and Primary Patient AML and CML Cells

Ahmed Ismail, PhD, Katarzyna Anna Mierzejewska, PhD, Anna Janowska-Wieczorek, MD PhD, A. Robert Turner, MD FRCPC, Mariusz Z Ratajczak, MD PhD, Magdalena Kucia, PhD
Journal: Blood
Blood (2014) 124 (21): 2204.
https://doi.org/10.1182/blood.V124.21.2204.2204
Published: 2014
Journal Articles

Aggressive Non-Hodgkin Lymphoma: Predictive Value Of Sarcopenia and Skeletal Muscle Density On Prognosis With Rituximab Containing Therapy

Michael P Chu, MD, Jessica Lieffers, Andrew R Belch, MD, Neil Chua, MD, FRCPC, Amelie Fontaine, MD, Randeep Sangha, A. Robert Turner, MD, FRCPC, Sunita Ghosh, PhD, Michael Sawyer, MD
Journal: Blood
Blood (2013) 122 (21): 3023.
https://doi.org/10.1182/blood.V122.21.3023.3023
Published: 2013
Journal Articles

A Randomized Trial Of Rituximab Vs Observation Following Autologous Stem Cell Transplantation (ASCT) For Relapsed Or Refractory CD20-Positive B Cell Lymphoma: Final Results Of NCIC CTG LY.12

Michael Crump, MD FRCPC, John Kuruvilla, MD, C. Tom Kouroukis, MD, MSc, FRCP(C), Ann Benger, MD, FRCP(C), Matthew C. Cheung, MD, FRCPC, Neil L Berinstein, MD, Stephen Couban, MD, FRCPC, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Kang Howson-Jan, MD, Armand Keating, MD, Massimo Federico, MD, David A Macdonald, MD, FRCPC, Harold J. Olney, MD, Morel Rubinger, MD, Michael Voralia, A. Robert Turner, MD, FRCPC, Tara Baetz, MD, Annette E Hay, MBChB, Marina Djurfeldt, MSc, Ralph M. Meyer, MD, Bingshu Chen, PhD, Lois Shepherd, M.D.
Journal: Blood
Blood (2013) 122 (21): 155.
https://doi.org/10.1182/blood.V122.21.155.155
Published: 2013
Journal Articles

Gemcitabine, Dexamethasone, Cisplatin (GDP) Compared to Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Prior to Autologous Stem Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: Final Results of the Randomized Phase III NCIC CTG Study LY12

Michael Crump, MD, FRCPC, John Kuruvilla, MD, FRCPC, Stephen Couban, MD, FRCPC, David Macdonald, MD, FRCPC, Vishal Kukreti, MD, C. Tom Kouroukis, MD, MSc, FRCPC, Ralph M. Meyer, MD, Morel Rubinger, MD, Rena Buckstein, MD, Kevin R Imrie, MD, Massimo Federico, MD, Nicola Di Renzo, MD, Kang Howson-Jan, MD, Tara Baetz, MD, Leonard Kaizer, MD FRCPC, Michael Voralia, MD, FRCPC, Harold J. Olney, MD, A. Robert Turner, MD, FRCPC, Jonathan Sussman, MD, Annette E Hay, MBChB, Marina Djurfeldt, MSc, Bingshu E Chen, PhD, Lois Shepherd, MD
Journal: Blood
Blood (2012) 120 (21): 745.
https://doi.org/10.1182/blood.V120.21.745.745
Published: 2012
Journal Articles

A Canadian Expanded Access Trial of Oral Nilotinb in Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Robert Delage, MD, MSc, FRCP, A. Robert Turner, MD, FRCPC, Brian Leber, MD, Wanda S. Hasegawa, MD, Denis-Claude Roy, MD, Mary Lynn Savoie, MD, Heather A Leitch, MD, PhD, Isabelle Bence-Bruckler, MD, FRCPC, Donna L. Forrest, MD, Sindu Kanjeekal, MD, Sehdev Sandeep, MD, Pierre Laneuville, MD, Sarit Assouline, MD, Kuljit Grewal, MD, Michael J. Kovacs, MD, FRCPC, Wendy Lam, MD, Annie Woo, M.Sc., Pierre Beauparlant, Ph.D., Jeffrey H. Lipton, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4437.
https://doi.org/10.1182/blood.V118.21.4437.4437
Published: 2011
Journal Articles

Nilotinib Responses and Tolerability Confirmed in North American Patients with Chronic Myeloid Leukemia (CML) From ENACT (Expanding Nilotinib Access in Clinical Trials).

Bayard L. Powell, MD, Hanna Jean Khoury, MD, Jeffrey H. Lipton, David A. Rizzieri, Denise Williams, MD, A. Robert Turner, MD, FRCPC
Journal: Blood
Blood (2009) 114 (22): 3295.
https://doi.org/10.1182/blood.V114.22.3295.3295
Published: 2009
Journal Articles

MT1-MMP Associates with Membrane Lipid Rafts and Is Required for G-CSF-Induced Hematopoietic Stem/Progenitor Cell Mobilization.

Neeta Shirvaikar, MSc, Leah A. Marquez-Curtis, PhD, BSc, Andrew Shaw, PhD, A. Robert Turner, MD, FRCPC, Anna Janowska-Wieczorek, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3536.
https://doi.org/10.1182/blood.V114.22.3536.3536
Published: 2009
Journal Articles

MMP-14 Mediates Migration of Acute Myelogenous Leukemia Cells

Neeta Shirvaikar, MSc, Ali Jalili, MSc, PhD, Imran Mirza, FRCPC, Sara Ilnitsky, BSc, Chris Korol, Loree M. Larratt, MD, A. Robert Turner, MD, FRCPC, Anna Janowska-Wieczorek, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2943.
https://doi.org/10.1182/blood.V112.11.2943.2943
Published: 2008
Journal Articles

The Potent Deacetylase Inhibitor Trichostatin a (TSA) Increases CXCR4 Expression in Hematopoietic Stem/Progenitor Cells by Chromatin Remodelling

Hilal Gul, PhD, MSc, Leah A. Marquez-Curtis, PhD, BSc, Jennifer Lo, Nadia Jahroudi, PhD, A. Robert Turner, MD, FRCPC, Loree M. Larratt, MD, Anna Janowska-Wieczorek, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3487.
https://doi.org/10.1182/blood.V112.11.3487.3487
Published: 2008